Young people in the United States are redefining the concept of “Dry January,” with many in the Gen Z demographic choosing to embrace sobriety as a...
Walking, a seemingly simple form of exercise, has gained attention as a potential full-body workout. Recent discussions highlight its benefits and effectiveness, prompting many to consider...
Michael Edward Schliebe, a respected husband, brother, and friend, passed away on December 7, 2025, following a brief battle with esophageal cancer. He was 70 years...
A recent study has revealed that a genetic mutation associated with schizophrenia can completely inhibit a specific brain receptor. This discovery comes at a time when...
Endurance is often perceived as a physical attribute, but recent insights reveal that it is primarily a mental construct. A growing body of evidence suggests that...
A significant population-based study has found that adults with type 2 diabetes (T2D) who initiate treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors experience a slightly lower risk...
Wegovy, the weight loss drug developed by Novo Nordisk, has officially launched its first pill version for obesity treatment in the United States. On March 4,...
As the new year begins, many individuals resolve to break old habits or adopt healthier ones. However, this year’s resolutions face challenges, particularly as holiday indulgences...
Aktis Oncology, a radiopharmaceutical startup, is planning to raise approximately $181.7 million in net proceeds through its upcoming initial public offering (IPO). This move marks a...
Novo Nordisk is set to launch the pill form of its obesity medication, Wegovy, in the United States on October 2, 2023. The company announced that...
